e-Therapeutics plc Company Profile (LON:ETX)

About e-Therapeutics plc (LON:ETX)

e-Therapeutics plc logoe-Therapeutics plc is a United Kingdom-based drug discovery and development company. The Company's discovery platform is based on the network of pharmacology and chemical biology. The Company operates in the business segment of drug discovery and development. The Company applies its platform to the discovery of new drug candidates. The therapeutic focus of the Company's discovery activity is in immuno-oncology, addressing drug resistance in targeted cancer therapies and antivirals. The Company generates a range of preclinical stage assets, including ETX1153c, a functionally resistance-less antibiotic; ETS2300, telomerase inhibition in anti-cancer; ETS3100, small molecule antiTNFα; ETS2400, in Hedgehog pathway inhibition, and ETS5200, which delivers a range of spectrum antivirals. The Company has completed a Phase IIb study of a drug candidate for depressive disorder, ETS6103, as well as Phase I clinical trials in cancer for ETS2101.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:ETX
  • CUSIP: N/A
  • Web: N/A
Capitalization:
  • Market Cap: £20.47 million
  • Outstanding Shares: 268,426,000
Average Prices:
  • 50 Day Moving Avg: GBX 8.24
  • 200 Day Moving Avg: GBX 8.31
  • 52 Week Range: GBX 7 - GBX 14.90
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.000
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: GBX 0.06 per share
  • Price / Book: 1.27
Profitability:
  • EBIDTA: ($13,470,000.00)
Misc:
  • Average Volume: 35,597 shs.
 

Frequently Asked Questions for e-Therapeutics plc (LON:ETX)

What is e-Therapeutics plc's stock symbol?

e-Therapeutics plc trades on the London Stock Exchange (LON) under the ticker symbol "ETX."

Who are some of e-Therapeutics plc's key competitors?

How do I buy e-Therapeutics plc stock?

Shares of e-Therapeutics plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of e-Therapeutics plc stock cost?

One share of e-Therapeutics plc stock can currently be purchased for approximately GBX 7.63.

Analyst Ratings

Consensus Ratings for e-Therapeutics plc (LON:ETX) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for e-Therapeutics plc (LON:ETX)
Show:
DateFirmActionRatingPrice TargetDetails
8/17/2015N+1 SingerReiterated RatingCorporateView Rating Details
(Data available from 5/27/2015 forward)

Earnings

Earnings History for e-Therapeutics plc (LON:ETX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for e-Therapeutics plc (LON:ETX)
Current Year EPS Consensus Estimate: $-3.600 EPS

Dividends

Dividend History for e-Therapeutics plc (LON:ETX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for e-Therapeutics plc (LON:ETX)
Insider Trades by Quarter for e-Therapeutics plc (LON:ETX)
Insider Trades by Quarter for e-Therapeutics plc (LON:ETX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/12/2017Trevor Mervyn JonesInsiderBuy59,400GBX 8£4,752
1/3/2017Trevor Mervyn JonesInsiderBuy36,917GBX 7£2,584.19
1/21/2015Steve MedlicottInsiderBuy150,000GBX 25.25£37,875
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for e-Therapeutics plc (LON:ETX)
Latest Headlines for e-Therapeutics plc (LON:ETX)
Source:
DateHeadline
americanbankingnews.com logoTrevor Mervyn Jones Acquires 59,400 Shares of e-Therapeutics plc (ETX) Stock
www.americanbankingnews.com - May 23 at 1:26 PM
finance.yahoo.com logoGridGain Helps e-Therapeutics Find Treatments for Biocomplex Diseases
finance.yahoo.com - May 17 at 10:32 AM
finance.yahoo.com logoe-Therapeutics plc: Appointment of Chief Executive Officer
finance.yahoo.com - May 17 at 10:32 AM
uk.finance.yahoo.com logoE-Therapeutics depression drug trials miss targets
uk.finance.yahoo.com - February 15 at 5:16 AM
uk.finance.yahoo.com logoBUZZ-E-therapeutics: biggest one-day drop as antidepressant study disappoints
uk.finance.yahoo.com - February 15 at 4:32 AM
uk.finance.yahoo.com logoe-Therapeutics plc Announces Full Year Results
uk.finance.yahoo.com - March 31 at 2:14 AM

Social

Social activity is not available for this stock.

Chart

e-Therapeutics plc (ETX) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by MarketBeat.com Staff